Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.43 |
| ▸ | AKR1A1 | P14550 | 2/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.43 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25576170 | 0.89 | PDK2 (0.48) | LMNAPDK2CHEK1PGR | |
| SCHEMBL10021525 | 0.86 | PDK2 (0.49) | LMNAPDK2AKR1A1AKR1B1CHEK1 | |
| SCHEMBL13085720 | 0.86 | PDK2 (0.47) | LMNAPDK2AKR1A1AKR1B1CHEK1 | |
| SCHEMBL13832926 | 0.83 | LMNA (0.51) | LMNAPDK2AKR1A1AKR1B1CHEK1 | |
| SCHEMBL29575912 | 0.82 | PDK2 (0.51) | LMNAPDK2AKR1A1AKR1B1MAPT | |
| SCHEMBL19850003 | 0.82 | PDK2 (0.51) | LMNAPDK2AKR1A1AKR1B1MAPT | |
| SCHEMBL25576166 | 0.81 | LMNA (0.41) | LMNAPDK2CHEK1PGRMAPT | |
| SCHEMBL22920879 | 0.80 | MEN1 (0.50) | LMNAPDK2AKR1A1AKR1B1MAPT | |
| SCHEMBL21037852 | 0.80 | PDK2 (0.49) | LMNAPDK2AKR1A1AKR1B1MAPT | |
| SCHEMBL30805716 | 0.80 | PDK2 (0.49) | LMNAPDK2AKR1A1AKR1B1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230165137-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
| US-20230165137-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165137-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SLC1A2, SLC18A1, SLC18A2 | LMNA 1352/4885PDK2 1385/4885AKR1A1 3607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.